Correlation Between China Airlines and Synmosa Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Airlines and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Airlines and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Airlines and Synmosa Biopharma, you can compare the effects of market volatilities on China Airlines and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Airlines with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Airlines and Synmosa Biopharma.

Diversification Opportunities for China Airlines and Synmosa Biopharma

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between China and Synmosa is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding China Airlines and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and China Airlines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Airlines are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of China Airlines i.e., China Airlines and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between China Airlines and Synmosa Biopharma

Assuming the 90 days trading horizon China Airlines is expected to generate 1.6 times more return on investment than Synmosa Biopharma. However, China Airlines is 1.6 times more volatile than Synmosa Biopharma. It trades about 0.05 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.01 per unit of risk. If you would invest  2,110  in China Airlines on August 26, 2024 and sell it today you would earn a total of  350.00  from holding China Airlines or generate 16.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

China Airlines  vs.  Synmosa Biopharma

 Performance 
       Timeline  
China Airlines 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in China Airlines are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, China Airlines showed solid returns over the last few months and may actually be approaching a breakup point.
Synmosa Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

China Airlines and Synmosa Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Airlines and Synmosa Biopharma

The main advantage of trading using opposite China Airlines and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Airlines position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.
The idea behind China Airlines and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Directory
Find actively traded commodities issued by global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges